Pellegrino Riccardo, Crimi Emanuele, Gobbi Alessandro, Torchio Roberto, Antonelli Andrea, Gulotta Carlo, Baroffio Michele, Papa Giuseppe Francesco Sferrazza, Dellacà Raffaele, Brusasco Vito
Allergologia e Fisiopatologia Respiratoria, ASO S. Croce e Carle, Cuneo, Italy;
Dipartimento di Medicina Interna e Specialità Mediche, Università di Genova, Genova, Italy;
J Appl Physiol (1985). 2015 Apr 1;118(7):796-802. doi: 10.1152/japplphysiol.00801.2014. Epub 2014 Nov 20.
Current guidelines recommend severity of chronic obstructive pulmonary disease be graded by using forced expiratory volume in 1 s (FEV1). But this measurement is biased by thoracic gas compression depending on lung volume and airflow resistance. The aim of this study was to test the hypothesis that the effect of thoracic gas compression on FEV1 is greater in emphysema than chronic bronchitis because of larger lung volumes, and this influences severity classification and prognosis. FEV1 was simultaneously measured by spirometry and body plethysmography (FEV1-pl) in 47 subjects with dominant emphysema and 51 with dominant chronic bronchitis. Subjects with dominant emphysema had larger lung volumes, lower diffusion capacity, and lower FEV1 than those with dominant chronic bronchitis. However, FEV1-pl, patient-centered variables (dyspnea, quality of life, exercise tolerance, exacerbation frequency), arterial blood gases, and respiratory impedance were not significantly different between groups. Using FEV1-pl instead of FEV1 shifted severity distribution toward less severe classes in dominant emphysema more than chronic bronchitis. The body mass, obstruction, dyspnea, and exercise (BODE) index was significantly higher in dominant emphysema than chronic bronchitis, but this difference significantly decreased when FEV1-pl was substituted for FEV1. In conclusion, the FEV1 is biased by thoracic gas compression more in subjects with dominant emphysema than in those with chronic bronchitis. This variably and significantly affects the severity grading systems currently recommended.
当前指南建议使用1秒用力呼气容积(FEV1)对慢性阻塞性肺疾病的严重程度进行分级。但该测量会受到胸腔气体压缩的影响,而胸腔气体压缩取决于肺容积和气流阻力。本研究的目的是检验以下假设:由于肺气肿患者的肺容积更大,胸腔气体压缩对FEV1的影响在肺气肿患者中比慢性支气管炎患者更大,这会影响严重程度分类和预后。对47例以肺气肿为主的患者和51例以慢性支气管炎为主的患者同时采用肺量计和体容积描记法测量FEV1(FEV1-pl)。以肺气肿为主的患者比以慢性支气管炎为主的患者肺容积更大、弥散功能更低且FEV1更低。然而,两组之间的FEV1-pl、以患者为中心的变量(呼吸困难、生活质量、运动耐量、急性加重频率)、动脉血气和呼吸阻抗并无显著差异。与慢性支气管炎相比,在以肺气肿为主的患者中使用FEV1-pl而非FEV1会使严重程度分布向较轻的类别偏移。以肺气肿为主的患者的体重指数、气道阻塞、呼吸困难和运动(BODE)指数显著高于慢性支气管炎患者,但当用FEV1-pl替代FEV1时,这种差异显著减小。总之,与慢性支气管炎患者相比,胸腔气体压缩对以肺气肿为主的患者的FEV1影响更大。这会对目前推荐的严重程度分级系统产生不同程度的显著影响。